← Back to Clinical Trials
Recruiting NCT06489080

NCT06489080 Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06489080
Status Recruiting
Phase
Sponsor Peking University First Hospital
Condition Acute Myocardial Infarction
Study Type OBSERVATIONAL
Enrollment 10,000 participants
Start Date 2024-03-01
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 10,000 participants in total. It began in 2024-03-01 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective and prospective cohort study aims to establish a long-term follow-up cohort of patients with acute myocardial infarction, and combine multi-omics studies, wearable devices, artificial intelligence technology, etc., to describe the clinical characteristics of patients with acute myocardial infarction and the changing trend of treatment strategies, and analyze the related influencing factors. Explore new biomarkers and indicators affecting recurrent cardiovascular events for accurate risk stratification and risk prediction; To evaluate the factors affecting lifestyle intervention, drug efficacy and safety, and their impact on outcome, and improve chronic disease management mode, in order to improve the quality of life and prognosis of patients.

Eligibility Criteria

Inclusion Criteria: * Acute myocardial infarction is diagnosed meets the universal definition of acute myocardial infarction Exclusion Criteria: * Did not agree to participate in the study

Contact & Investigator

Central Contact

Jia Jia, MPH

✉ jiajia9985@163.com

📞 861083572283

Frequently Asked Questions

Who can join the NCT06489080 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06489080 currently recruiting?

Yes, NCT06489080 is actively recruiting participants. Contact the research team at jiajia9985@163.com for enrollment information.

Where is the NCT06489080 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06489080 clinical trial?

NCT06489080 is sponsored by Peking University First Hospital. The trial plans to enroll 10,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology